Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Xia Zhang, Yaru Li, Xinchen Wei, Yali Hou, Siqi Jia, Siqi Li & Xiujuan Zhao. (2021) Metabolomics analysis of the effects of quercetin on hepatotoxicity induced by acrylamide exposure in rats. Free Radical Research 55:7, pages 732-742.
Read now
Read now
Articles from other publishers (28)
Valentina Cossiga, Maria Guarino, Mario Capasso & Filomena Morisco. (2023) Relevance of Bile Acids in Cholangiocarcinoma Pathogenesis: Critical Revision and Future Directions. Cells 12:12, pages 1576.
Crossref
Crossref
Faraz Ahmad, Priyanka Saha, Vineeta Singh, Mohd Wahid, Raju K. Mandal, Bhartendu Nath Mishra, Sharmila Fagoonee & Shafiul Haque. (2023) Diet as a modifiable factor in tumorigenesis: Focus on microbiome-derived bile acid metabolites and short-chain fatty acids. Food Chemistry 410, pages 135320.
Crossref
Crossref
Maria Consiglia Bragazzi, Rosanna Venere, Anthony Vignone, Domenico Alvaro & Vincenzo Cardinale. (2023) Role of the Gut–Liver Axis in the Pathobiology of Cholangiopathies: Basic and Clinical Evidence. International Journal of Molecular Sciences 24:7, pages 6660.
Crossref
Crossref
Li Qi & Yongsheng Chen. (2023) Circulating Bile Acids as Biomarkers for Disease Diagnosis and Prevention. The Journal of Clinical Endocrinology & Metabolism 108:2, pages 251-270.
Crossref
Crossref
Boyan Zhang, Zhiqiang Sun, Zhu Yu, Haihai Li, Hailing Luo & Bing Wang. (2022) Transcriptome and targeted metabolome analysis provide insights into bile acids' new roles and mechanisms on fat deposition and meat quality in lamb. Food Research International 162, pages 111941.
Crossref
Crossref
Bichitra Paul, Monika Lewinska & Jesper B. Andersen. (2022) Lipid alterations in chronic liver disease and liver cancer. JHEP Reports 4:6, pages 100479.
Crossref
Crossref
Ludovica Ceci, Tianhao Zhou, Ilaria Lenci, Vik Meadows, Lindsey Kennedy, Ping Li, Burcin Ekser, Martina Milana, Wenjun Zhang, Chaodong Wu, Keisaku Sato, Sanjukta Chakraborty, Shannon S. Glaser, Heather Francis, Gianfranco Alpini & Leonardo Baiocchi. (2022) Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development. Cancers 14:6, pages 1442.
Crossref
Crossref
Cecilia Binda, Giulia Gibiino, Chiara Coluccio, Monica Sbrancia, Elton Dajti, Emanuele Sinagra, Gabriele Capurso, Vittorio Sambri, Alessandro Cucchetti, Giorgio Ercolani & Carlo Fabbri. (2022) Biliary Diseases from the Microbiome Perspective: How Microorganisms Could Change the Approach to Benign and Malignant Diseases. Microorganisms 10:2, pages 312.
Crossref
Crossref
Junhao Fu, Min Yu, Wenxia Xu & Shian Yu. (2022) Research Progress of Bile Acids in Cancer. Frontiers in Oncology 11.
Crossref
Crossref
Mustafa Korkmaz & Mehmet Artaç. 2022.
Łukasz Krupa, Robert Staroń, Dorota Dulko, Natalia Łozińska, Alan R. Mackie, Neil M. Rigby, Adam Macierzanka, Aleksandra Markiewicz & Christian Jungnickel. (2021) Importance of Bile Composition for Diagnosis of Biliary Obstructions. Molecules 26:23, pages 7279.
Crossref
Crossref
Yihang Gong, Kun Li, Yunfei Qin, Kaining Zeng, Jianrong Liu, Shaozhuo Huang, Yewu Chen, Haoyuan Yu, Wei Liu, Linsen Ye & Yang Yang. (2021) Norcholic Acid Promotes Tumor Progression and Immune Escape by Regulating Farnesoid X Receptor in Hepatocellular Carcinoma. Frontiers in Oncology 11.
Crossref
Crossref
Thanika KetpueakParameth ThiennimitrNattayaporn ApaijaiSiriporn C. ChattipakornNipon Chattipakorn. (2021) Association of Chronic Opisthorchis Infestation and Microbiota Alteration on Tumorigenesis in Cholangiocarcinoma. Clinical and Translational Gastroenterology 12:1, pages e00292.
Crossref
Crossref
Xiaofen Zhang, Ziyao Yang, Ziyu Shi, Zijia Zhu, Cai Li, Zhicheng Du, Yiding Zhang, Zipeng Wang, Zhenrui Jiao, Xin Tian, Ji Zhang, Wenlong Zhai & Quancheng Kan. (2021) Analysis of bile acid profile in plasma to differentiate cholangiocarcinoma from benign biliary diseases and healthy controls. The Journal of Steroid Biochemistry and Molecular Biology 205, pages 105775.
Crossref
Crossref
Deepthi Y. Tulasi, Diego Martinez Castaneda, Kortney Wager, Connor B. Hogan, Karel P. Alcedo, Jesse R. Raab & Adam D. Gracz. (2021) Sox9EGFP Defines Biliary Epithelial Heterogeneity Downstream of Yap Activity. Cellular and Molecular Gastroenterology and Hepatology.
Crossref
Crossref
Xiaodong Jia, Shanshan Lu, Zhen Zeng, Qingyan Liu, Zheng Dong, Yan Chen, Zhenyu Zhu, Zhixian Hong, Ting Zhang, Guifang Du, Jiao Xiang, Dawei Wu, Wenlin Bai, Bin Yang, Yinyin Li, Jiagan Huang, Haiyang Li, Rifaat Safadi & Yinying Lu. (2019) Characterization of Gut Microbiota, Bile Acid Metabolism, and Cytokines in Intrahepatic Cholangiocarcinoma. Hepatology 71:3, pages 893-906.
Crossref
Crossref
Peter L. Labib, George Goodchild & Stephen P. Pereira. (2019) Molecular Pathogenesis of Cholangiocarcinoma. BMC Cancer 19:1.
Crossref
Crossref
Leonardo Baiocchi, Tianhao Zhou, Suthat Liangpunsakul, Ilaria Lenci, Francesco Santopaolo, Fanyin Meng, Lindsey Kennedy, Shannon Glaser, Heather Francis & Gianfranco Alpini. (2019) Dual Role of Bile Acids on the Biliary Epithelium: Friend or Foe?. International Journal of Molecular Sciences 20:8, pages 1869.
Crossref
Crossref
Ziyan Chen, Pengyi Guo, Xiaozai Xie, Haitao Yu, Yi Wang & Gang Chen. (2019) The role of tumour microenvironment: a new vision for cholangiocarcinoma. Journal of Cellular and Molecular Medicine 23:1, pages 59-69.
Crossref
Crossref
Hermin Aminah Usman, Bethy S. Hernowo, Maringan Diapari Lumban Tobing & Reti Hindritiani. (2018) The Major Role of NF-κB in the Depth of Invasion on Acral Melanoma by Decreasing CD8+ T Cells. Journal of Pathology and Translational Medicine 52:3, pages 164-170.
Crossref
Crossref
Kathleen Deutschmann, Maria Reich, Caroline Klindt, Carola Dröge, Lina Spomer, Dieter Häussinger & Verena Keitel. (2018) Bile acid receptors in the biliary tree: TGR5 in physiology and disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1864:4, pages 1319-1325.
Crossref
Crossref
O. Erice, I. Labiano, A. Arbelaiz, A. Santos-Laso, P. Munoz-Garrido, R. Jimenez-Agüero, P. Olaizola, A. Caro-Maldonado, N. Martín-Martín, A. Carracedo, E. Lozano, J.J. Marin, C.J. O'Rourke, J.B. Andersen, J. Llop, V. Gómez-Vallejo, D. Padro, A. Martin, M. Marzioni, L. Adorini, M. Trauner, L. Bujanda, M.J. Perugorria & J.M. Banales. (2018) Differential effects of FXR or TGR5 activation in cholangiocarcinoma progression. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1864:4, pages 1335-1344.
Crossref
Crossref
Ali Mteyrek, Elisabeth Filipski, Catherine Guettier, Malgorzata Oklejewicz, Gijsbertus T.J. van der Horst, Alper Okyar & Francis Lévi. (2017) Critical cholangiocarcinogenesis control by cryptochrome clock genes. International Journal of Cancer 140:11, pages 2473-2483.
Crossref
Crossref
Wei Wang, Ming Zhan, Qi Li, Wei Chen, Huiling Chu, Qihong Huang, Zhaoyuan Hou, Mohan Man & Jian Wang. (2016)
FXR agonists enhance the sensitivity of biliary tract cancer cells to cisplatin
via
SHP dependent inhibition of Bcl-xL expression
. Oncotarget 7:23, pages 34617-34629.
Crossref
Crossref
Runping Liu, Xiaojiaoyang Li, Xiaoyan Qiang, Lan Luo, Phillip B. Hylemon, Zhenzhou Jiang, Luyong Zhang & Huiping Zhou. (2015) Taurocholate Induces Cyclooxygenase-2 Expression via the Sphingosine 1-phosphate Receptor 2 in a Human Cholangiocarcinoma Cell Line. Journal of Biological Chemistry 290:52, pages 30988-31002.
Crossref
Crossref
Sumet Amonyingcharoen, Tawit Suriyo, Apinya Thiantanawat, Piyajit Watcharasit & Jutamaad Satayavivad. (2015) Taurolithocholic acid promotes intrahepatic cholangiocarcinoma cell growth via muscarinic acetylcholine receptor and EGFR/ERK1/2 signaling pathway. International Journal of Oncology.
Crossref
Crossref
Luca Maroni, Gianfranco Alpini & Marco Marzioni. (2014) Cholangiocarcinoma development: The resurgence of bile acids. Hepatology 60:3, pages 795-797.
Crossref
Crossref
Runping Liu, Renping Zhao, Xiqiao Zhou, Xiuyin Liang, Deanna J.W. Campbell, Xiaoxuan Zhang, Luyong Zhang, Ruihua Shi, Guangji Wang, William M. Pandak, Alphonse E. Sirica, Phillip B. Hylemon & Huiping Zhou. (2014) Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1‐phosphate receptor 2. Hepatology 60:3, pages 908-918.
Crossref
Crossref